相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Surveillance after Complete Response to First-Line Chemotherapy in Patients with Metastatic Nonseminomatous Germ Cell Tumor
Jennifer M. King et al.
JOURNAL OF UROLOGY (2022)
Surveillance of postchemotherapy subcentimeter residual retroperitoneal mass in metastatic nonseminomatous germ cell tumor: Does how you measure matter?
Cody E. Cotner et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)
Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor
Gregory J. Nason et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Actual frequency of imaging during follow-up of testicular cancer in Israela comparison with the guidelines
Anna-Therese Lehnich et al.
EUROPEAN RADIOLOGY (2019)
Somatic Transformation in Metastatic Testicular Germ Cell Tumours - A Different Disease Entity
Anand Sharma et al.
ANTICANCER RESEARCH (2019)
Modified retroperitoneal lymph node dissection for post-chemotherapy residual tumour: a long-term update
Jane S. Cho et al.
BJU INTERNATIONAL (2017)
Late Relapse of Testicular Germ Cell Tumors
Matthew J. O'Shaughnessy et al.
UROLOGIC CLINICS OF NORTH AMERICA (2015)
Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance
Peter Chung et al.
CANCER MEDICINE (2015)
A meta-analysis of patient outcomes with subcentimeter disease after chemotherapy for metastatic non-seminomatous germ cell tumor
P. Ravi et al.
ANNALS OF ONCOLOGY (2014)
Cancer Treatment and Survivorship Statistics, 2014
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Risk Factors for Loss to Follow-up During Active Surveillance of Patients with Stage I Seminoma
Tsuyoshi Endo et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2014)
Surveillance for Stage I Nonseminoma Testicular Cancer: Outcomes and Long-Term Follow-Up in a Population-Based Cohort
Gedske Daugaard et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Management of Disseminated Nonseminomatous Germ Cell Tumors With Risk-Based Chemotherapy Followed by Response-Guided Postchemotherapy Surgery
Christian Kollmannsberger et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-Term Follow-Up of Cisplatin Combination Chemotherapy in Patients With Disseminated Nonseminomatous Germ Cell Tumors: Is a Postchemotherapy Retroperitoneal Lymph Node Dissection Needed After Complete Remission?
Yaron Ehrlich et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer
Vairavan S. Subramanian et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Retroperitoneal lymph node dissection: reassessment of modified templates
Michael C. Large et al.
BJU INTERNATIONAL (2009)
Postchemotherapy Retroperitoneal Lymph Node Dissection in Advanced Testicular Cancer: Radical or Modified Template Resection
Axel Heidenreich et al.
EUROPEAN UROLOGY (2009)
POST-CHEMOTHERAPHY RETROPERITONEAL LYMPH NODE DISSECTION FOR TESTICULAR GERM CELL TUMORS: IS SURGERY INDICATED IN ALL AND IS BILATERAL TEMPLATE NECESSARY? PRINCESS MARGARET HOSPITAL EXPERIENCE
David Kakiashvili et al.
JOURNAL OF UROLOGY (2009)
High rate of retroperitoneal teratoma despite complete remission after chemotherapy for metastatic nonseminomatous germ cell tumor
Hannes Steiner et al.
JOURNAL OF UROLOGY (2007)
Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection for men with CII non-seminomatous germ cell tumors and a radiographically normal retroperitoneum.
Michael Karellas et al.
JOURNAL OF UROLOGY (2007)
Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy
EA Ronnen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses
J Oldenburg et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors:: Prognostic factors and role of postsurgery chemotherapy-results from an international study group
K Fizazi et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
